We serve Chemical Name:6-Nitro-1H-indazole-3-carbaldehyde CAS:315203-37-3 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:6-Nitro-1H-indazole-3-carbaldehyde
CAS.NO:315203-37-3
Synonyms:6-Nitro-1H-indazole-3-carboxaldehyde;1H-Indazole-3-carboxaldehyde, 6-nitro-;1H-INDAZOLE-3-CARBOXALDEHYDE,6-NITRO;6-nitroindazole-3-carbaldehyde;6-Nitro-1H-indazole-3-carbaldehyde;6-Nitro indazole-3-carboxaldehyde
Molecular Formula:C8H5N3O3
Molecular Weight:191.144
HS Code:2933990090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:463.5±25.0 °C at 760 mmHg
Density:1.6±0.1 g/cm3
Index of Refraction:1.783
PSA:91.57000
Exact Mass:191.033096
LogP:1.28
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 6-Nitro-1H-indazole-3-carboxaldehyde chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,6-Nitro indazole-3-carboxaldehyde physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,6-Nitro indazole-3-carboxaldehyde Use and application,6-Nitro-1H-indazole-3-carbaldehyde technical grade,usp/ep/jp grade.
Related News: “They will now look to re-engage with the FDA to better understand the bar donanemab needs to clear to potentially obtain a more expedited regulatory approval.” 6-Nitro-1H-indazole-3-carbaldehyde manufacturer ICIG is a privately owned industrial holding company focusing on mid-sized chemicals and pharmaceutical businesses. 6-Nitro-1H-indazole-3-carbaldehyde supplier “They will now look to re-engage with the FDA to better understand the bar donanemab needs to clear to potentially obtain a more expedited regulatory approval.” 6-Nitro-1H-indazole-3-carbaldehyde vendor “They will now look to re-engage with the FDA to better understand the bar donanemab needs to clear to potentially obtain a more expedited regulatory approval.” 6-Nitro-1H-indazole-3-carbaldehyde factory “They will now look to re-engage with the FDA to better understand the bar donanemab needs to clear to potentially obtain a more expedited regulatory approval.”
